TMCnet News

Molecular Cytogenetics Market to Reach $2.52 Billion by 2021: Growing Usage of Molecular Cytogenetic Techniques in Clinical Pathological Testing - Research and Markets
[February 02, 2017]

Molecular Cytogenetics Market to Reach $2.52 Billion by 2021: Growing Usage of Molecular Cytogenetic Techniques in Clinical Pathological Testing - Research and Markets


Research and Markets has announced the addition of the "Molecular Cytogenetics Market - Forecast to 2021" report to their offering.

The molecular cytogenetics market is projected to reach USD 2.52 Billion by 2021 from USD 1.55 Billion in 2016, at a CAGR of 10.1% from 2016 to 2021.

The global molecular cytogenetics market is segmented based on product, technique, application, end user, and region. The kits and reagents segment is expected to register the highest growth rate in the molecular cytogenetics market, by product, during the forecast period. The high growth in this segment is attributed to the increasing number of rental agreements and increasing incidence of genetic disorders and cancer worldwide. However, the high cost of advanced instruments in emerging economies is restraining the growth of this market.

Based on end users, the molecular cytogenetics market is classified into clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and others. The clinical and research laboratories segment is expected to account or the largest share of the global molecular cytogenetics market in 2016. The large number of molecular cytogenetic tests performed in clinical and research laboratories will drive the growth of this market during the forecast period.



The major factors contributing to the growth of the global molecular cytogenetics market include the increasing incidence of genetic disorders and cancer, growing usage of molecular cytogenetic techniques in clinical pathological testing, and rising aging population. On the other hand, high cost of advanced instruments and unfavorable reimbursement scenario are the major factors restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the molecular cytogenetics market.

Companies Mentioned:


  • ABBott Laboratories, Inc.
  • Agilent (News - Alert) Technologies, Inc.
  • Applied Spectral Imaging
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-LA Roche Ltd.
  • Illumina, Inc.
  • Oxford Gene Technology (OGT)
  • Perkinelmer, Inc.
  • Thermo Fisher Scientific Inc.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Molecular Cytogenetics Market, By Product

7 Molecular Cytogenetics Market, By Technique

8 Molecular Cytogenetics Market, By Application

9 Molecular Cytogenetics Market, By End User

10 Molecular Cytogenetics Market, By Region

11 Competitive Landscape

12 Company Profiles

13 Appendix

For more information about this report visit http://www.researchandmarkets.com/research/k64nrn/molecular


[ Back To TMCnet.com's Homepage ]